Interesting thoughts but for me it feels like something a director with not much skin in the game would do, to ensure ongoing fees and cash to use. My thought is still mr Tribe would want to cash in some time in the next few years but i could well be wrong. I guess i just use my own standard that if i wasnt looking for a return on investment of however many millions he has in now while i am alive then why not just take my 200 million or whatever it is and kick back in st Moritz or monaco. I saw a company become 1 billion valuation on phase 2 trials AMD see below but i assume that has a much wider patient base than our current target. Would be nice to hit a more common untreatable indication.
"Earlier this year Optheabecame a $1 billion company, after phase 2 trials saw significant progress in treating some cases of age-related macular degeneration (AMD), an eye disease which can cause blindness, when its potential new drug is used jointly with a commonly used treatment."
PYC Price at posting:
6.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)